Serum Anti-Mullerian Hormone Levels before Surgery in Patients with Ovarian Endometriomas Compared to Other Benign Ovarian Cysts.
10.6118/jmm.2015.21.3.142
- Author:
Ji Hyun JEON
1
;
So Yun PARK
;
Sa Ra LEE
;
Kyungah JEONG
;
Hye Won CHUNG
Author Information
1. Department of Obstetrics and Gynecology, School of Medicine, Ewha Womans University, Seoul, Korea. ogjeong@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Anti-Mullerian hormone;
Endometriosis;
Ovarian cysts;
Ovarian reserve
- MeSH:
Anti-Mullerian Hormone*;
Endometriosis*;
Female;
Humans;
Ovarian Cysts*;
Pathology;
Retrospective Studies
- From:Journal of Menopausal Medicine
2015;21(3):142-148
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: To evaluate preoperative anti-Mullerian hormone (AMH) levels in women with endometrioma or other benign ovarian cysts and differences of AMH changes according to various characteristics. METHODS: Ninety-seven patients aged 20 to 39 years who underwent surgery for benign ovarian cyst were enrolled retrospectively. Of these, 65 patients were diagnosed as endometriomas, and 32 had other benign cysts. Serum AMH, mean, maximum, and total diameter of ovarian cysts were measured. The AMH levels were compared according to pathology (endometrioma vs. other benign cyst), size of ovarian cyst, age-matched AMH quartile percentile and characteristics of endometrioma. RESULTS: Preoperative serum AMH level was significantly lower in endometrioma group than other benign cyst group (4.12 +/- 2.42 ng/mL vs. 6.02 +/- 2.29 ng/mL, P < 0.001). Serum AMH level was significantly lower in endometrioma group, especially in patients aged 30 to 39 years. Dividing to age-matched AMH quartile percentile, there were significantly fewer patients with AMH level > or = 75 percentile in endometrioma group (24.6% vs. 50.0%, P = 0.035). Among 4 subgroups of endometrioma, patients with AMH level > or = 75 percentile were significantly decreased in multiple bilateral endometrioma group. Mean and total diameter of cysts were negatively correlated with preoperative serum AMH level in other benign cyst group. CONCLUSION: We suggest that preoperative AMH level measurement might be considered in women with endometrioma, especially in 30 to 39 years old, multiple bilateral type, or big-sized other benign ovarian cyst to assess the diminished ovarian reserve.
